Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Org Lett ; 20(10): 2980-2983, 2018 05 18.
Article in English | MEDLINE | ID: mdl-29745673

ABSTRACT

A practical method for the nucleophilic substitution (S N) of alcohols furnishing alkyl chlorides, bromides, and iodides under stereochemical inversion in high catalytic efficacy is introduced. The fusion of diethylcyclopropenone as a simple Lewis base organocatalyst and benzoyl chloride as a reagent allows notable turnover numbers up to 100. Moreover, the use of plain acetyl chloride as a stoichiometric promotor in an invertive S N-type transformation is demonstrated for the first time. The operationally straightforward protocol exhibits high levels of stereoselectivity and scalability and tolerates a variety of functional groups.

2.
Oncotarget ; 8(2): 3259-3273, 2017 Jan 10.
Article in English | MEDLINE | ID: mdl-27965462

ABSTRACT

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and show characteristics of skeletal muscle differentiation. The two major RMS subtypes in children are alveolar (ARMS) and embryonal RMS (ERMS). We demonstrate that approximately 50% of ARMS and ERMS overexpress the LEF1/TCF transcription factor LEF1 when compared to normal skeletal muscle and that LEF1 can restrain aggressiveness especially of ARMS cells. LEF1 knockdown experiments in cell lines reveal that depending on the cellular context, LEF1 can induce pro-apoptotic signals. LEF1 can also suppress proliferation, migration and invasiveness of RMS cells both in vitro and in vivo. Furthermore, LEF1 can induce myodifferentiation of the tumor cells. This may involve regulation of other LEF1/TCF factors i.e. TCF1, whereas ß-catenin activity plays a subordinate role. Together these data suggest that LEF1 rather has tumor suppressive functions and attenuates aggressiveness in a subset of RMS.


Subject(s)
Lymphoid Enhancer-Binding Factor 1/metabolism , Rhabdomyosarcoma/metabolism , Rhabdomyosarcoma/pathology , Apoptosis/genetics , Biomarkers, Tumor , Biopsy , Cell Differentiation/genetics , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation , Disease Progression , Gene Expression , Gene Knockdown Techniques , Humans , Lymphoid Enhancer-Binding Factor 1/genetics , Neoplasm Grading , Rhabdomyosarcoma/genetics , Tissue Array Analysis , Wnt Signaling Pathway
SELECTION OF CITATIONS
SEARCH DETAIL
...